Lee Tom Y
- SEC CIK
- 0001623609
No open-market purchases or sales filed in the past year.
Current role at each company
- PURE Pure Bioscience, Inc.Director, 10% Owneras of Aug 22, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lee Tom Y as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 (view filing)6:48 PM ET | Dec 15 | 4 days | Lee Tom YChief Executive Officer | PPurchase | +50.0K | $0.131 | +$6.55K | +1.0%5.00M after | |
| Mar 22, 2022 (view filing)9:49 PM ET | Mar 16-21 | 6 daysLate | Lee Tom YChief Executive Officer | PPurchase | +219.5K | $0.1951 | +$42.8K | +4.6%4.95M after | 3 lots |